Mirikizumab in patients with ulcerative colitis – cases from clinical practice
Milan Lukáš1, Dominik Bettenworth2, Viktorie Zacharová1
+ Affiliation
Summary
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Colwill M, Baillie S, Clough J et al. Role of Mirikizumab in the treatment of inflammatory bowel disease. From bench to bedside. J Clin Med 2025; 14(3): 1001. doi: 10.3390/jcm14031001.